Xeris Biopharma Holdings
XERS
XERS
103 hedge funds and large institutions have $150M invested in Xeris Biopharma Holdings in 2021 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 39 increasing their positions, 25 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
7% more funds holding
Funds holding: 96 → 103 (+7)
2.32% less ownership
Funds ownership: 52.37% → 50.05% (-2.3%)
Holders
103
Holding in Top 10
–
Calls
$10.3M
Puts
$1.35M
Top Buyers
| 1 | +$29.6M | |
| 2 | +$4.31M | |
| 3 | +$1.58M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.5M |
| 5 |
Morgan Stanley
New York
|
+$1.24M |
Top Sellers
| 1 | -$3.4M | |
| 2 | -$3.09M | |
| 3 | -$877K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$715K |
| 5 |
Voloridge Investment Management
Jupiter,
Florida
|
-$663K |